← Evidence map

ReviewTherapeutic advances in hematology2022

An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment.

Meletios A Dimopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35392438